Construction and Characterization of a Novel Fusion Protein MG7-scFv/SEB against Gastric Cancer
Figure 8
Ten gastric-cancer-bearing rats in each group were observed for their survival time after being administrated with MG7-scFv/SEB, SEB, or NS. The survival times of the rats in MG7-scFv/SEB and SEB group were longer than that of NS group within 60-day observation (). There were statistic differences among the three groups ().